Кардиоваскулярные риски и комплексное лечение рака молочной железы, актуальность проблемы и пути решения

Abstract

For many years cardiovascular disease and cancer pathology occupy leading positions in the structure of morbidity, disability and mortality. One of the negative aspects of a comprehensive cancer treatment is the side effects of the cardiovascular system. Premature atherosclerotic vascular lesions with the development of coronary heart disease, damage to the pericardium and the valve apparatus, the occurrence of various disorders of rhythm and conduction, the development of cardiomyopathy progression refractory to standard therapy of chronic heart failure is significantly lower quality of life and are the most common causes of disability of patients cured from cancer.